Oral Formulation of Angiotensin-(1-7) Improves Lipid Metabolism and Prevents High-Fat Diet-Induced Hepatic Steatosis and Inflammation in Mice

被引:78
作者
Feltenberger, John David [1 ,4 ]
Oliveira Andrade, Joao Marcus [1 ]
Paraiso, Alanna [1 ]
Barros, Lucas Oliveira [1 ]
Maia Filho, Aristides Batista [1 ]
Sinisterra, Ruben D. M. [3 ]
Sousa, Frederico B. [3 ]
Sena Guimaraes, Andre Luiz [1 ]
Batista de Paula, Alfredo Mauricio [1 ]
Campagnole-Santos, Maria Jose [3 ]
Qureshi, Mahboob [4 ]
Souza dos Santos, Robson Augusto [3 ]
Sousa Santos, Sergio Henrique [1 ,2 ]
机构
[1] Univ Estadual Montes Claros, Postgrad Program Hlth Sci, Lab Hlth Sci, Montes Claros, MG, Brazil
[2] Univ Fed Minas Gerais, Dept Pharmacol, Inst Biol Sci, BR-31270901 Belo Horizonte, MG, Brazil
[3] Univ Fed Minas Gerais, Natl Inst Sci & Technol Nanobiopharmaceut, BR-31270901 Belo Horizonte, MG, Brazil
[4] Touro Univ Nevada, Coll Med, Sch Med, Las Vegas, NV USA
关键词
angiotensina-(1-7); fatty liver; lipid metabolism; obesity; visceral steatosis; congenital; INCREASED ENERGY-EXPENDITURE; LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; GLUCOSE-METABOLISM; GENE-EXPRESSION; TRANSGENIC RATS; INDUCED OBESITY; INSULIN; RECEPTOR; DELETION;
D O I
10.1161/HYPERTENSIONAHA.111.00919
中图分类号
R6 [外科学];
学科分类号
100210 [外科学];
摘要
Angiotensin (Ang)-(1-7) has been described as an important tool on treating and preventing metabolic disorders. In this study, we aimed to evaluate the effect of an oral formulation of Ang-(1-7) included in hydroxypropyl-cyclodextrin (HPCD/Ang-[1-7]) on hepatic function, steatosis, and on liver inflammatory markers expression in mice treated with a high-fat diet. Male FVB/N mice were divided into 4 groups and fed for 60 days, with each group receiving 1 of the following diets: standard diet+HPCD, standard diet+Ang-(1-7)/HPCD, high-fat diet+HPCD, or high-fat diet+Ang-[1-7]/HPCD. Body weight, food intake, and blood parameters, such as total cholesterol, triglyceride, alaninetransaminases, and aspartate transaminases, were evaluated. Immunohistochemical analyses were performed for inflammatory markers tumor necrosis factor- and interleukin-6. Expression of angiotensin converting enzyme, angiotensin-converting enzyme-2, interleukin-1, tumor necrosis factor-, interleukin-6, transforming growth factor-, acetyl-CoA carboxylase, carbohydrate-responsive element-binding protein, peroxisome proliferator-activated receptor-, and sterol regulatory element-binding proteins-1c was evaluated by quantitative real-time polymerase chain reaction. The major findings of our study included reduced liver fat mass and weight, decreased plasma total cholesterol, triglyceride, and alaninetransaminase enzyme levels in the oral Ang-(1-7)-treated groups compared with the control groups. These results were accompanied by a significant reduction in tumor necrosis factor- and interleukin-6 mRNA expression in the liver. Analyses of liver adipogenesis-related genes by quantitative real-time polymerase chain reaction showed that acetyl-CoA carboxylase, peroxisome proliferator-activated receptor-, and sterol regulatory element-binding proteins-1c mRNA expression were significantly suppressed. In conclusion, we observed that treatment with Ang-(1-7) improved metabolism and decreased proinflammatory profile and fat deposition in liver of mice.
引用
收藏
页码:324 / 330
页数:7
相关论文
共 47 条
[1]
Acetyl-CoA Carboxylase 2-/- Mutant Mice are Protected against Fatty Liver under High-fat, High-carbohydrate Dietary and de Novo Lipogenic Conditions [J].
Abu-Elheiga, Lutfi ;
Wu, Hongmei ;
Gu, Ziwei ;
Bressler, Rubin ;
Wakil, Salih J. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (15) :12578-12588
[2]
Decreased hepatic gluconeogenesis in transgenic rats with increased circulating angiotensin-(1-7) [J].
Bilman, Victor ;
Mares-Guia, Lucas ;
Nadu, Ana Paula ;
Bader, Michael ;
Campagnole-Santos, Maria Jose ;
Santos, Robson Augusto S. ;
Santos, Sergio Henrique S. .
PEPTIDES, 2012, 37 (02) :247-251
[3]
Insulin resistance: A metabolic pathway to chronic liver disease [J].
Bugianesi, E ;
McCullough, AJ ;
Marchesini, G .
HEPATOLOGY, 2005, 42 (05) :987-1000
[4]
A high-fat diet leads to the progression of non-alcoholic fatty liver disease in obese rats [J].
Carmiel-Haggai, M ;
Cederbaum, AI ;
Nieto, N .
FASEB JOURNAL, 2004, 18 (14) :136-+
[5]
Hepatitis C virus:: The viral way to fatty liver [J].
Clement, Sophie ;
Negro, Francesco .
JOURNAL OF HEPATOLOGY, 2007, 46 (06) :985-987
[6]
Non-alcoholic steatohepatitis: From cell biology to clinical practice [J].
Cortez-Pinto, H ;
de Moura, MC ;
Day, CP .
JOURNAL OF HEPATOLOGY, 2006, 44 (01) :197-208
[7]
Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients [J].
Crespo, J ;
Cayón, A ;
Fernández-Gil, P ;
Hernández-Guerra, M ;
Mayorga, M ;
Domínguez-Díez, A ;
Fernández-Escalante, JC ;
Pons-Romero, F .
HEPATOLOGY, 2001, 34 (06) :1158-1163
[8]
Current therapeutic strategies in non-alcoholic fatty liver disease [J].
Dowman, J. K. ;
Armstrong, M. J. ;
Tomlinson, J. W. ;
Newsome, P. N. .
DIABETES OBESITY & METABOLISM, 2011, 13 (08) :692-702
[9]
Weight loss and the renin-angiotensin-aldosterone system [J].
Engeli, S ;
Bohnke, J ;
Gorzelniak, K ;
Janke, J ;
Schling, P ;
Bader, M ;
Luft, FC ;
Sharma, AM .
HYPERTENSION, 2005, 45 (03) :356-362
[10]
Nonalcoholic fatty liver disease: From steatosis to cirrhosis [J].
Farrell, GC ;
Larter, CZ .
HEPATOLOGY, 2006, 43 (02) :S99-S112